Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMH as a marker of ovarian reserve in young breast cancer patients receiving chemotherapy plus GnRH analogue
2012-005337-37Phase 2Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Mar 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of triptorelin in breast cancer, primary ovarian insufficiency (POI), sponsored by Humanitas Research Hospital. Started Mar 2013; status: completed.
02
Drugs
triptorelin
03
Conditions
breast cancerprimary ovarian insufficiency (POI)
Beyond the preview
Go deeper on 2012-005337-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005337-37.